Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

Clinical trial NCT06601504 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06601504
Sponsor: Hutchmed
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Start date: 2024-11-05
Primary completion: 2026-05-12
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.